Protalix BioTherapeutics Inc (PLX)
1.335
+0.08
(+6.80%)
USD |
NYAM |
Nov 04, 13:08
Protalix BioTherapeutics Shareholders Equity (Quarterly): 28.58M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 28.58M |
March 31, 2024 | 29.79M |
December 31, 2023 | 33.57M |
September 30, 2023 | 38.25M |
June 30, 2023 | 39.00M |
March 31, 2023 | 1.008M |
December 31, 2022 | -10.64M |
September 30, 2022 | -11.51M |
June 30, 2022 | -9.889M |
March 31, 2022 | -7.486M |
December 31, 2021 | -6.036M |
September 30, 2021 | 0.213M |
June 30, 2021 | 3.841M |
March 31, 2021 | 14.50M |
December 31, 2020 | -27.04M |
September 30, 2020 | -33.32M |
June 30, 2020 | -34.76M |
March 31, 2020 | -30.88M |
December 31, 2019 | -70.32M |
September 30, 2019 | -70.85M |
June 30, 2019 | -67.48M |
March 31, 2019 | -59.86M |
December 31, 2018 | -52.88M |
September 30, 2018 | -64.99M |
June 30, 2018 | -49.57M |
Date | Value |
---|---|
March 31, 2018 | -39.44M |
December 31, 2017 | -29.46M |
September 30, 2017 | -26.07M |
June 30, 2017 | -20.67M |
March 31, 2017 | -68.47M |
December 31, 2016 | -9.957M |
September 30, 2016 | -15.10M |
June 30, 2016 | -7.976M |
March 31, 2016 | 2.65M |
December 31, 2015 | 10.87M |
September 30, 2015 | -68.51M |
June 30, 2015 | -65.14M |
March 31, 2015 | -61.15M |
December 31, 2014 | -55.60M |
September 30, 2014 | -47.69M |
June 30, 2014 | -39.79M |
March 31, 2014 | -33.58M |
December 31, 2013 | -26.95M |
September 30, 2013 | -16.71M |
June 30, 2013 | -11.99M |
March 31, 2013 | -6.283M |
December 31, 2012 | -3.357M |
September 30, 2012 | 4.772M |
June 30, 2012 | 7.863M |
March 31, 2012 | -6.457M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-70.32M
Minimum
Dec 2019
39.00M
Maximum
Jun 2023
-2.796M
Average
-6.036M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
Aethlon Medical Inc | 8.713M |
Predictive Oncology Inc | 4.094M |
bluebird bio Inc | 52.98M |
AIM ImmunoTech Inc | 6.102M |
Armata Pharmaceuticals Inc | -46.10M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 91.54M |
Total Liabilities (Quarterly) | 62.96M |
Debt to Equity Ratio | 0.7145 |
Current Ratio | 1.335 |
Net Debt Paydown Yield | 1.83% |